Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,083 | -1,009 | -360 | -2,834 | -1,439 |
| Depreciation Amortization | 392 | 196 | 98 | 729 | 448 |
| Income taxes - deferred | N/A | N/A | N/A | 1 | N/A |
| Accounts receivable | 300 | -3 | 362 | 81 | 211 |
| Accounts payable and accrued liabilities | 49 | 201 | -70 | -29 | -17 |
| Other Working Capital | -75 | -118 | 434 | 1,070 | 497 |
| Other Operating Activity | -66 | 57 | -260 | 825 | 304 |
| Operating Cash Flow | $-483 | $-677 | $203 | $-158 | $4 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -28 | N/A | -55 | N/A | 0 |
| PPE Investments | -129 | -100 | -63 | -122 | 35 |
| Net Acquisitions | -114 | N/A | N/A | 16 | N/A |
| Purchase Of Investment | N/A | -55 | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | -76 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -1 | 0 |
| Investing Cash Flow | $-271 | $-155 | $-118 | $-183 | $35 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 379 | -64 | -44 | 121 | 196 |
| Debt Repayment | -911 | 141 | -233 | 399 | -47 |
| Common Stock Issued | 438 | 243 | 26 | 1,744 | 332 |
| Other Financing Activity | -28 | 0 | 0 | -1,253 | -748 |
| Financing Cash Flow | $-121 | $319 | $-251 | $1,011 | $-267 |
| Exchange Rate Effect | 128 | -39 | 1 | -4 | 12 |
| Beginning Cash Position | 1,491 | 1,491 | 1,491 | 825 | 824 |
| End Cash Position | 744 | 939 | 1,326 | 1,491 | 608 |
| Net Cash Flow | $-747 | $-551 | $-165 | $666 | $-216 |
| Free Cash Flow | |||||
| Operating Cash Flow | -483 | -677 | 203 | -158 | 4 |
| Capital Expenditure | -129 | -100 | -63 | -122 | 35 |
| Free Cash Flow | -612 | -777 | 140 | -280 | 39 |